Summary by Moomoo AI
On February 7, 2024, CVS Health Corporation reported its fourth quarter and full-year results for the period ending December 31, 2023. The company announced an 11.9% increase in total revenues for the quarter, reaching $93.8 billion, and a 10.9% increase for the full year, totaling $357.8 billion. GAAP diluted EPS was $1.58 for the quarter and $6.47 for the full year, while Adjusted EPS was $2.12 for the quarter and $8.74 for the full year. The company also generated $13.4 billion in cash flow from operations during the year. CVS Health revised its 2024 full-year guidance, lowering GAAP diluted EPS to at least $7.06 from $7.26, Adjusted EPS to at least $8.30 from $8.50, and cash flow from operations to at least $12.0 billion from $12.5 billion, due to elevated medical cost trends. CVS Health President and CEO...Show More